Your browser doesn't support javascript.
loading
An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer.
Lu, Xin; Pan, Xiaolu; Wu, Chang-Jiun; Zhao, Di; Feng, Shan; Zang, Yong; Lee, Rumi; Khadka, Sunada; Amin, Samirkumar B; Jin, Eun-Jung; Shang, Xiaoying; Deng, Pingna; Luo, Yanting; Morgenlander, William R; Weinrich, Jacqueline; Lu, Xuemin; Jiang, Shan; Chang, Qing; Navone, Nora M; Troncoso, Patricia; DePinho, Ronald A; Wang, Y Alan.
Afiliação
  • Lu X; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pan X; Department of Biological Sciences, Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, Indiana.
  • Wu CJ; Tumor Microenvironment and Metastasis Program, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana.
  • Zhao D; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Feng S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zang Y; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee R; Department of Biological Sciences, Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, Indiana.
  • Khadka S; Department of Biostatistics, Indiana University, Indianapolis, Indiana.
  • Amin SB; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jin EJ; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shang X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Deng P; Department of Biological Science, Wonkwang University, Cheonbuk, Iksan, South Korea.
  • Luo Y; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Morgenlander WR; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Weinrich J; Department of Biological Sciences, Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, Indiana.
  • Lu X; Department of Biological Sciences, Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, Indiana.
  • Jiang S; Department of Biological Sciences, Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, Indiana.
  • Chang Q; Department of Biological Sciences, Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, Indiana.
  • Navone NM; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Troncoso P; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • DePinho RA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang YA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Res ; 78(14): 3823-3833, 2018 07 15.
Article em En | MEDLINE | ID: mdl-29769196
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Peptídeos e Proteínas de Sinalização Intracelular Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Peptídeos e Proteínas de Sinalização Intracelular Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article